
AlphaVue runs 20+ AI agents in parallel to deliver a BUY/HOLD/SELL verdict with a full evidence.
Grounded in available product and source data
A single AI-generated stock rating with no visible reasoning behind it is hard to actually trust or act on — AlphaVue offers AI stock research with a full evidence trail instead, showing the debate and analysis behind a verdict rather than just the conclusion.
A stated 20+ AI agents work in parallel rather than sequentially, split across specific roles — a Market Agent tracking price and technicals, an Earnings Agent analyzing valuation and earnings quality, a News Agent catching catalysts, and a Sentiment Agent reading market mood — so a verdict draws on several distinct angles gathered at once rather than one general-purpose model skimming a single data source.
That verdict itself goes through a stated four-stage process — Gather Intel, Cross-Examine, Stress-Test, and Deliver Verdict — ending in a BUY, HOLD, or SELL call with a stated confidence and risk level, a bull-versus-bear debate laid out explicitly, and a 3-perspective risk stress-test rather than a single risk score.
Once a position is analyzed, auto-alerts are built to fire specifically when the underlying thesis changes, aiming to remove the need to check a stock manually every day just in case something shifted. Signing up and creating a first stock analysis requires no credit card. The page reviewed does not specify AlphaVue's historical verdict accuracy or track record, and — as with any automated investment research — its output is worth treating as one input for independent research rather than a instruction to act on directly; verify current data and consider consulting a financial professional before making an investment decision.
No — a bull-vs-bear debate and a full evidence trail are shown alongside the verdict specifically so the reasoning behind it is visible, not just the final call.
The page reviewed does not define the exact threshold for a thesis change, worth confirming directly if precise alert sensitivity matters for an actively managed position.
The page reviewed does not describe personalization of the verdict itself, so a given stock's analysis is presumably the same for every user rather than tailored per investor.
The page reviewed does not quantify how agent count affects reliability specifically, framing the parallel, role-specific structure as the reasoning behind using 20+ agents rather than one general model.


